Isometric diagram of a glowing teal growth-factor protein binding a dimeric cell-surface receptor in a membrane with a downward branching amber signaling cascade, representing growth-factor receptor signaling
Mindful Research

Growth-Factor and Secretagogue Research Compounds: Extended Overview

Updated By: Mindful Research Team1 min read

Key takeaways

  • Growth-factor and secretagogue research compounds are studied in vitro for growth-factor receptor interaction.
  • A growth factor engages its own receptor; a secretagogue acts upstream.
  • Many growth-factor receptors are receptor tyrosine kinases (RTKs) activating PI3K-Akt.
  • Example compounds: IGF-1 LR3 (modified analog) and sermorelin (GHRH analog).
  • Studied with cell-based receptor-activation and pathway-signaling assays.

Growth-factor and secretagogue research compounds are peptides studied in vitro for their interaction with growth-factor receptors and the downstream signaling pathways those receptors activate. This extended overview builds on the GH-secretagogue basics.

Growth factors vs secretagogues

A growth factor is a signaling protein that engages its own receptor directly. A secretagogue is a compound studied for its interaction with receptors upstream of growth-factor systems. Both are studied as distinct tool classes.

Key receptor pathways

Many growth-factor receptors are receptor tyrosine kinases (RTKs), which activate downstream pathways such as the PI3K-Akt pathway. These pathways are the readouts in cell-based studies.

Example compounds

The supporting guides profile IGF-1 LR3, a modified growth-factor analog, and sermorelin, a GHRH-analog reference compound, each as a defined research material.

How they are studied in vitro

Researchers use cell-based assays that read out receptor activation and downstream pathway signaling, under controlled conditions and with proper controls.

Related research guides

Research-use note

All compounds referenced are supplied for in vitro laboratory research use only. They are not for human or animal use.

Related research: Growth factor receptor signaling in vitro rtk pi3k akt.

Frequently asked questions

What is the difference between a growth factor and a secretagogue?

A growth factor engages its own receptor directly; a secretagogue is studied for interaction with receptors upstream of growth-factor systems.

What receptor pathways are studied?

Many growth-factor receptors are receptor tyrosine kinases that activate downstream pathways such as PI3K-Akt.

What are example compounds?

IGF-1 LR3, a modified growth-factor analog, and sermorelin, a GHRH-analog reference compound. View IGF-1 LR3

How are they studied in vitro?

With cell-based assays reading out receptor activation and downstream pathway signaling, with proper controls.

Research use only?

Yes, in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOWGLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison) The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's...